http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2665633-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562836a86397c1fe8330319a51515e30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 |
| filingDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab06325c1474afa01d3b33f22612a71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d540a9fc0ff44e4f7bbda8248d45fc19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1255b847db449e48e663509e60699ca4 |
| publicationDate | 2018-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2665633-C1 |
| titleOfInvention | New inhibitor of glutaminyl cyclase and its use |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to pharmaceutical composition for modulating the activity of glutaminyl cyclase, and also for treatment of a disorder associated with glutaminyl cyclase activity containing an effective amount of a compound of N,N'-bis[2-(1H-imidazol-4-yl)ethyl]isophthalamide. n . n EFFECT: implementation of invention will yield effective glutaminyl cyclase modulator having a high activity with respect to intracellular and/or secreted isoforms of glutaminyl cyclase and good pharmacokinetic characteristics. n 11 cl, 10 ex, 6 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114874186-A |
| priorityDate | 2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 198.